Stephen Senn
Head, Methodology and Statistics Group,
Competence Center for Methodology and Statistics (CCMS),
Luxembourg
Delta Force
To what extent is clinical relevance relevant?
Inspiration
This note has been inspired by a Twitter exchange with respected scientist and famous blogger David Colquhoun. He queried whether a treatment that had 2/3 of an effect that would be described as clinically relevant could be useful. I was surprised at the question, since I would regard it as being pretty obvious that it could but, on reflection, I realise that things that may seem obvious to some who have worked in drug development may not be obvious to others, and if they are not obvious to others are either in need of a defence or wrong. I don’t think I am wrong and this note is to explain my thinking on the subject. Continue reading